Abstract: Salivary gland adenocarcinoma not otherwise specified (NOS) is a malignant epithelial tumor composed of ductal/glandular structures with or without cystic formation. Histologically it is classified as high grade with relevant biological behavior. Although both minor and major glands may be involved, the majority (60%) implicate the parotid gland. Location, regional lymph node status, and histological grade are some of the factors that predict the progress of the disease and the development of metastases. Long follow-up is considered the standard option as.......
Key words: Adenocarcinoma, Distant Metastases, Lymph nodes, Uterine leiomyoma, Posterior uterine, Libya
[1]. Morita M, Murase T, Okumura Y, Ueda K, Sakamoto Y And Masaki A (2020) Clinicopathological Significance Of EGFR Pathway Gene Mutations And CRTC1/3-MAML2 Fusions In Salivary Gland Mucoepidermoid Carcinoma. Histopathology, 76(7):1013–1022.
[2]. Nachtsheim L, Arolt C, Dreyer T, Meyer MF, Brobeil A And Gamerdinger U (2020) Mucoepidermoidcarcinoma – Importance In Molecular Pathology. Laryngo Rhino Otology, 99(3):144–148.
[3]. Wang K, Mcdermott JD, Schrock AB, Elvin JA, Gay L And Karam SD (2017) Comprehensive Genomic Profiling Of Salivary Mucoepidermoid Carcinomas Reveals Frequent BAP1, PIK3CA, And Other Actionable Genomic Alterations. Annals Oncology, 28(4):748–753.
[4]. Boon E, Bel M, Van Boxtel W, Van Der Graaf WTA, Van RJJ And Eerenstein Es SEJ (2018) A Clinicopathological Study And Prognostic Factor Analysis Of 177 Salivary Duct Carcinoma Patients From The Netherlands. International Journal Cancer, 143(4):758–766.
[5]. Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR And Sweeney C (2018) Targeted Therapy For Advanced Solid Tumors On The Basis Of Molecular Profiles: Results From Mypathway, An Open-Label, Phase Iia Multiple Basket Study. Journals Clinical Oncology, 36(6):536–542..